T.R | Title | User | Personal Name | Date | Lines |
---|
435.1 | Addition without current documentation | CSC32::M_EVANS | | Thu Oct 11 1990 12:34 | 16 |
| I unfortunately chucked the paper into the recycle, but an article in
the Rocky Mountain News Sunday magazine by Trisha Flynn had an
interesting piece of data. Trisha Flynn is Denver's local Ellen
Goodman-type columnist.
Anyway, she had and article on research in medicine and woman. I don't
have the exact reference she used, but would you believe there was a
study done on the connection between obesity and breast and cervical
cancer done in the eighties. The study subjects were obese men!!!!
Trisha explained that while obese men may have breasts, she still
hasn't seen a man with a cervix. The NIH's excuse was that women's
hormones are too complicated. Ms. Flynn's tart comment, was if that's
the case why isn't there a male pill if male reproduction hormones are
less complex.
Meg
|
435.2 | | ULTRA::WITTENBERG | Secure Systems for Insecure People | Sat Oct 13 1990 16:07 | 32 |
| There's a mixture of real problems and complete nonsense in this,
and since it is widely repeated, it's worth seperating them.
Start by dividing medical research into 4 categories: Female
diseases (eg. cervical cancer), Male diseases(eg. prostate
cancer), diseases of both sexes that seem to behave differently in
the different sexes (eg. heart disease), and disease of both sexes
that seem to behave similarly in both sexes (eg. appendicitis).
Assuming the article's numbers are accurate, 13% on the NIH budget
is spent on the first category. But far less is spent on the
second. There's far more research on breast cancer than on
prostate cancer. In this area it seems that there is more interest
in women's health than in men's.
The real problem comes in the third category. Most work on
diseases that affect both sexes has been done on males for a
variety of reasons. It's simpler not having to worry about
periodic hormonal changes. There was no need to worry about
experimental treatment harming a fetus. It may have been easier to
get volunteers. In the case of work with animals, you didn't have
to wonder what effect pregnancies had on the experiment. After a
while, there was more data on males, so it's easier to fit new
information in.
Obviously there will have to be more work done on how disease
affect women (as well as more work on exclusively male diseases),
but in the current atmosphere of cutting funds for research
(research funds have been decreasing in constant dollars for 10
years), I wouldn't hold my breath.
--David
|
435.3 | excuses, excuses | COBWEB::SWALKER | it's not easy being green... | Mon Oct 15 1990 12:00 | 44 |
|
> The real problem comes in the third category. Most work on
> diseases that affect both sexes has been done on males for a
> variety of reasons. It's simpler not having to worry about
> periodic hormonal changes.
(...)
> In the case of work with animals, you didn't have
> to wonder what effect pregnancies had on the experiment.
I dunno, David, but I call these "excuses", not "reasons". The
result of not doing research on women is that you don't KNOW what
effect menstruation or pregnancy has on the treatment's effectiveness.
And yet, physicians use these studies to prescribe drugs for
menstruating, and sometimes even pregnant, women as a matter of
course... although "it works on rats but we've never tested it with
humans" is *not* enough to get FDA approval.
You don't have to wonder if you don't care about knowing. Isn't
that really the bottom line?
> ... After a
> while, there was more data on males, so it's easier to fit new
> information in.
(...)
> Obviously there will have to be more work done on how disease
> affect women (as well as more work on exclusively male diseases),
Research involving only male subjects has not traditionally been
seen as incomplete. This is perhaps my most compelling reason
for finding your argument, while in some respects theoretically
sound, a woefully incorrect representation of reality.
> but in the current atmosphere of cutting funds for research
> (research funds have been decreasing in constant dollars for 10
> years), I wouldn't hold my breath.
"Yeah", says the cynic in me, "Let's spend the money on lots of
research on men, then announce there's none left for the women."
(Note: it's not going to do any good to flame this remark, which
is made in the spirit of "just because you're paranoid doesn't
mean they're not out to get you")
Sharon
|
435.4 | | ULTRA::WITTENBERG | Secure Systems for Insecure People | Mon Oct 15 1990 15:08 | 15 |
| Running biological experiments is hard, particularly on people,
where you can't keep them in a known environment. Trying to reduce
the number of variables is standard in any experimental set up.
I'm talking mainly about basic research, where budgets are much
more limited and the number of variables one is looking at are
much larger than drug research.
The good news is that a column in the November "Scientific
American" discussing the toxicity of dioxin and related compounds
does have seperated data for male and female rats, and it turns
out that there is one compound that is toxic to males and not to
females, and one that is toxic to females and not to males.
--David
|